Standardization of diagnostic immunohistochemistry: Literature review and Geisinger experience

Archives of Pathology and Laboratory Medicine

Volumn 138, Issue 12, 2014, Pages 1564-1577

  Lin, Fan ^a   Chen, Zongming ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY; PATHOLOGY; STANDARDS;

HUMANS; IMMUNOHISTOCHEMISTRY; LABORATORIES; PATHOLOGY, CLINICAL;

EID: 84914695477     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2014-0074-RA     Document Type: Article

References (107)

1. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256(5517):495-497.
2. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffinembedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 1991;39(6):741-748.
3. Shi SR, Tandon AK, Cote C, Kalra KL. S-100 protein in human inner ear: use of a novel immunohistochemical technique on routinely processed, celloidin-embedded human temporal bone sections. Laryngoscope. 1992;102(7):734-738.
4. Shi SR, Tandon AK, Haussmann RR, Kalra KL, Taylor CR. Immunohistochemical study of intermediate filament proteins on routinely processed, celloidin-embedded human temporal bone sections by using a new technique for antigen retrieval. Acta Otolaryngol. 1993;113(1):48-54.
5. Shi SR, Cote C, Kalra KL, Tandon CR, Tandon AK. A technique for retrieving antigens in formalin-fixed, routinely acid-decalcified, celloidin-embedded human temporal bone sections for immunohistochemistry. J Histochem Cytochem. 1992;40(6):787-792.
6. Gown AM, de Wever N, Battifora H. Microwave-based antigenic unmasking: a revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem. 1993;1:256-266.
7. Leong AS-Y, Milios J. An assessment of the efficacy of the microwave antigen-retrieval procedure on a range of tissue antigens. Appl Immunohistochem. 1993;1:267-274.
8. Taylor CR, Shi SR, Chen C, Young L, Yang C, Cote RJ. Comparative study of antigen retrieval heating methods: microwave, microwave and pressure cooker, autoclave, and steamer. Biotech Histochem. 1996;71(5):263-270.
9. Taylor CR, Shi SR, Cote RJ. Antigen retrieval for immunohistochemistry: status and need for greater standardization. Appl Immunohistochem. 1996;4:144-166.
10. Shi S-R, Cote RJ, Taylor CR. Antigen retrieval immunohistochemistry: past, present, and future. J Histochem Cytochem. 1997;45(3):327-343.
11. Taylor CR, Burns J. The demonstration of plasma cells and other immunoglobulin-containing cells in formalin-fixed, paraffin-embedded tissues using peroxidase labelled antibody. J Clin Pathol. 1974;27(1):14-20.
12. DeLellis RA, Sternberger LA, Mann RB, Banks PM, Nakane PK. Immunoperoxidase techniques in diagnostic pathology: report of a workshop sponsored by the National Cancer Institute. Am J Clin Pathol. 1979;71(5):483-488.
13. Hsu SM, Raine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol. 1981;75(5):734-738.
14. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29(4):577-580.
15. Bobrow MN, Harris TD, Shaughnessy KJ, Litt GJ. Catalyzed reporter deposition: a novel method of signal amplification: application to immunoassays. J Immunol Methods. 1989;125(1-2):279-285.
16. Adams JC. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem. 1992;40(10):1457-1463.
17. Heras A, Roach CM, Key ME. Enhanced polymer detection system for immunohistochemistry. Mod Pathol. 1995;8:165A.
18. Tsutsumi Y, Serizawa A, Kawai K. Enhanced polymer one-step staining (EPOS) for proliferation cell nuclear antigen (PCNA) and Ki-67 antigen: application to intra-operative frozen diagnosis. Path Int. 1995;45(2):108-115.
19. Van der Loos CM, Naruko T, Becker AE. The use of enhanced polymer one-step staining reagents for immunoenzyme double-labelling. Histochem J. 1996;28(10):709-714.
20. Kammerer U, Kapp M, Gassel AM, et al. A new rapid immunohistochemical staining technique using the EnVision antibody complex. J Histochem Cytochem. 2001;49(5):623-630.
21. Bisgaard K, Pulzek K. Use of polymer conjugated in immunohistochemistry: a comparative study of a traditional staining method to a staining method utilizing polymer conjugates [abstract]. Path Int. 1996;46(suppl 1):577.
22. Sabattini E, Bisgaard K, Ascani S, et al. The EnVision system: a new immunohistochemical method for diagnostics and research: critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol. 1998;51(7):506-511.
23. Vyberg M, Nielsen S. Dextran polymer conjugate two-step visualization system for immunohistochemistry. Appl Immunohistochem. 1998;6:3.
24. Toda Y, Kono K, Abiru H, et al. Application of tyramide signal amplification system to immunohistochemistry: a potent method to localize antigens that are not detectable by ordinary method. Pathol Int. 1999;49(5):479-483.
25. Mengel M, Werner M, von Wasielewski R. Concentration dependent and adverse effects in immunohistochemistry using the tyramine amplification technique. Histochem J. 1999;31(3):195-200.
26. Herman GE, Elfont EA, Floyd AD. Overview of automated immunostainers. Methods Mol Biol. 1994;34:383-403.
27. Le Neel T, Moreau A, Laboisse C, et al. Comparative evaluation of automated systems in immunohistochemistry. Clin Chim Acta. 1998;278(2):185-192.
28. Moreau A, Le Neel T, Joubert M, Truchaud A, Laboisse C. Approach to automation in immunohistochemistry. Clin Chim Acta. 1998;278(2):177-184.
29. Taylor C. Issues in using whole slide imaging for diagnostic pathology: "routine" stains, immunohistochemistry and predictive markers [published online ahead of print December 11, 2013]. Biotech Histochem. doi:10.3109/10520295.2013.861512.
30. Shinde V, Burke KE, Chakravarty A, et al. Applications of pathologyassisted image analysis of immunohistochemistry-based biomarkers in oncology. Vet Pathol. 2014;51(1)202-303.
31. Keay T, Conway CM, O'Flaherty N, Hewitt SM, Shea K, Gavrielides MA. Reproducibility in the automated quantitative assessment of HER2/neu for breast cancer. J Pathol Inform. 2013;4:19.
32. Kondo Y, Iijima T, Noguchi M. Evaluation of immunohistochemical staining using whole-slide imaging for HER2 scoring of breast cancer in comparison with real glass slides. Pathol Int. 2012;62(9):592-599.
33. Camparo P, Egevad L, Algaba F, et al. Utility of whole slide imaging and virtual microscopy in prostate pathology. APMIS. 2012;120(4):298-304.
34. Feldman MD. Beyond morphology: whole slide imaging, computer-aided detection, and other techniques. Arch Pathol Lab Med. 2008;132(5):758-763.
35. Laurinavicius A, Laurinaviciene A, Ostapenko V, Dasevicius D, Jarmalaite S, Lazutka J. Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data. Diagn Pathol. 2012;7:27.
36. Goldstein NS, Hewitt SM, Taylor CR, et al. Recommendations for improved standardization of immunohistochemistry. Appl Immunohistochem Mol Morphol. 2007;15(2):124-133.
37. Werner M, Chott A, Fabiano A, Battifora H. Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol. 2000;24(7):1016-1019.
38. Williams JH, Mepham BL, Wright DH. Tissue preparation for immunocytochemistry. J Clin Pathol. 1997;50(5):422-428.
39. Goldstein NS, Ferkowicz M, Odish E, Mani A, Hastah F. Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. Am J Clin Pathol. 2003;120(1):86-92.
40. Mason JT, O'Leary TJ. Effects of formaldehyde fixation on protein secondary structure: a calorimetric and infrared spectroscopic investigation. J Histochem Cytochem. 1991;39(2):225-229.
41. Evers P, Uylings HB. Microwave-stimulated antigen retrieval is pH and temperature dependent. J Histochem Cytochem. 1994;42(12):1555-1563.
42. Zhang PJ, Wang H, Wrona EL, Cheney RT. Effects of tissue fixatives on antigen preservation for immunohistochemistry: a comparative study of microwave antigen retrieval on Lillie fixative and neutral buffered formalin. J Histotechnol. 1998;21(2):101-106.
43. Grabau DA, Nielsen O, Hansen S, et al. Influence of storage temperature and high-temperature antigen retrieval buffers on results of immunohistochemical staining in sections stored for long periods. Appl Immunohistochem. 1998;6(4):209-213.
44. Jacobs TW, Prioleau JE, Stillman IE, Schnitt SJ. Loss of tumor markerimmunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst. 1996;88(15):1054-1059.
45. Wester K, Wahlund E, Sundstrom C, et al. Paraffin section storage and immunohistochemistry: effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen. Appl Immunohistochem Mol Morphol. 2000;8(1):61-70.
46. Cuevas EC, Bateman AC, Wilkins BS, et al. Microwave antigen retrieval in immunocytochemistry: a study of 80 antibodies. J Clin Pathol. 1994;47(5):448-452.
47. Lee H, Douglas-Jones AG, Morgan JM, Jasani B. The effect of fixation and processing on the sensitivity of oestrogen receptor assay by immunohistochemistry in breast carcinoma. J Clin Pathol. 2002;55(3):236-238.
48. Skacel M, Skilton B, Pettay JD, Tubbs RR. Tissue microarrays: a powerful tool for high-throughput analysis of clinical specimens: a review of the method with validation data. Appl Immunohistochem Mol Morphol. 2002;10(1):1-6.
49. Mengel M, Kreipe M, vonWasielewski R. Rapid and large-scale transition of new tumor biomarkers to clinical biopsy material by innovative tissue microarray systems. Appl Immunohistochem Mol Morphol. 2003;11(3):261-268.
50. Leong AS, Gilham PN. The effects of progressive formaldehyde fixation on the preservation of tissue antigens. Pathology. 1989;21(4):266-268.
51. Shi SR, Cote RJ, Chaiwun B, et al. Standardization of immunohistochemistry based on antigen retrieval technique for routine formalin-fixed tissue sections. Appl Immunohistochem. 1998;6:89-96.
52. Seidal T, Balaton AJ, Battifora H. Interpretation and quantification of immunostains. Am J Surg Pathol. 2001;25(9):1204-1207.
53. Leong AS. Quantitation in immunohistology: fact or fiction; a discussion of variables that influence results. Appl Immunohistochem Mol Morphol. 2004;12(1):1-7.
54. Rhodes A, Jasani B, Anderson E, Dodson AR, Balaton AJ. Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries. Am J Clin Pathol. 2002;118(3):408-417.
55. Rhodes A, Jasani B, Balaton AJ, Miller KD. Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol. 2000;53(4):292-301.
56. Taylor CR, Levenson RM. Quantification of immunohistochemistry: issues concerning methods, utility and semiquantitative assessment II. Histopathology. 2006;49(4):411-424.
57. Mengel M, von Wasielewski R, Wiese B, Rüdiger T, Müller-Hermelink HK, Kreipe H. Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J Pathol. 2002;198(3):292-299.
58. Xie R, Chung JY, Ylaya K, et al. Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections. J Histochem Cytochem. 2011;59(4):356-365.
59. Portier BP, Wang Z, Downs-Kelly E, et al. Delay to formalin fixation 'cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistry. Mod Pathol. 2013;26(1):1-9.
60. Arber DA. Effect of prolonged formalin fixation on the immunohistochemical reactivity of breast markers. Appl Immunohistochem Mol Morphol. 2002;10(2):183-186.
61. Hardy LB, Fitzgibbons PL, Goldsmith JD, et al. Immunohistochemistry validation procedures and practices: a College of American Pathologists survey of 727 laboratories. Arch Pathol Lab Med. 2013;137(1):19-25.
62. Fox CH, Johnson FB, Whiting J, Roller PP. Formaldehyde fixation. J Histochem Cytochem. 1985;33(8):845-853.
63. Fetsch PA, Abati A. Overview of the clinical immunohistochemistry laboratory: regulations and troubleshooting guidelines. Methods Mol Biol. 1999;115:405-414.
64. Rickert RR, Maliniak RM. Intralaboratory quality assurance of immunohistochemical procedures: recommended practices for daily application. Arch Pathol Lab Med. 1989;113(6):673-679.
65. Hewitt SM, Robinowitz M, Bogen SA, et al. Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays; Approved Guidelines. Vol 31. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2011.
66. Yaziji H, Taylor C, Goldstein NS, et al; Members of the Standardization Ad-Hoc Consensus Committee. Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry. Appl Immunohistochem Mol Morphol. 2008;16(6):513-520.
67. Nagle RB, Fitzgibbons PL. Consensual interpretive guidelines for diagnostic immunohistochemistry [comment on Am J Surg Pathol. 2001;25(9):1208-1210.] Am J Surg Pathol. 2002;26(6):816-817..
68. O'Leary TJ. Standardization in immunohistochemistry. Appl Immunohistochem Mol Morphol. 2001;9(1):3-8.
69. Ramos-Vara JA, Kiupel M, Baszler T, et al. Suggested guidelines for immunohistochemical techniques in veterinary diagnostic laboratories. J Vet Diagn Invest. 2008;20(4):393-413.
70. Hammond ME, Fitzgibbons PL, Compton CC, et al. College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how, and so what: summary document and recommendations for implementation; Members of the Cancer Committee and Conference Participants. Arch Pathol Lab Med. 2000;124(7):958-965.
71. Torlakovic EE, Naresh K, Kremer M, van der Walt J, Hyjek E, Porwit A. Call for a European programme in external quality assurance for bone marrow immunohistochemistry: report of a European Bone Marrow Working Group pilot study. J Clin Pathol. 2009;62(6):547-551.
72. Taylor CR. FDA issues final rule for classification and reclassification of immunochemistry reagents and kits. Am J Clin Pathol. 1999;111(4):443-444.
73. Taylor CR. Quality assurance and standardization in immunohistochemistry: a proposal for the annual meeting of the Biological Stain Commission, June, 1991. Biotech Histochem. 1992;67(2):110-117.
74. Taylor CR. Report from the Biological Stain Commission: FDA issues final rule for classification/reclassification of immunochemistry (IHC) reagents and kits. Biotech Histochem. 1998;73(4):175-177.
75. Taylor CR. Report of the Immunohistochemistry Steering Committee of the Biological Stain Commission: "Proposed format: package insert for immunohistochemistry products." Biotech Histochem. 1992;67(6):323-338.
76. UK NEQAS: United Kingdom National External Quality Assessment Service. http://www.ukneqas.org.uk. Accessed January 18 and 19, 2014.
77. NordiQC: Nordic immunohistochemical quality control. http://www.nordiqc.org. Accessed January 18 and 19, 2014.
78. Shi SR, Liu C, Taylor CR. Standardization of immunohistochemistry for formalin-fixed, paraffin-embedded tissue sections based on the antigen-retrieval technique: from experiments to hypothesis. J Histochem Cytochem. 2007;55(2):105-109.
79. Taylor CR. The total test approach to standardization of immunohistochemistry. Arch Pathol Lab Med. 2000;124(7):945-951.
80. Yaziji H, Barry T. Diagnostic immunohistochemistry: what can go wrong? Adv Anat Pathol. 2006;13(5):238-246.
81. Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee; Torlakovic EE, Riddell R, Banerjee D, et al. Canadian Association of Pathologists-Association canadienne des pathologists National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests. Am J Clin Pathol. 2010;133(3):354-365.
82. Engel KB, Moore HM. Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med. 2011;135(5):537-543.
83. Taylor CR. New revised clinical and laboratory standards institute guidelines for immunohistochemistry and immunocytochemistry. Appl Immunohistochem Mol Morphol. 2011;19(4):289-290.
84. Morken T, Ruegg P. Validation and quality control for immunohistochemistry. Presented at: National Society for Histotechnology Symposium, Workshop No. 86; September 29, 2010; Seattle, WA. http://www.nsh.org/content/validation-and-quality-control-immunohistochemistry. Accessed January 4 and 5, 2014.
85. Nakleh RE, Fitzgibbons PL. Quality Management in Anatomic Pathology: Promoting Patient Safety Through Systems Improvement and Error Reduction. Northfield, IL: CAP Press; 2005:93-110.
86. Shi SR, Gu J, Cote RJ, et al. Standardization of routine immunohistochemistry: where to begin. In: Shi S-R, Gu J, Taylor CR, eds. Antigen Retrieval Technique: Immunohistochemistry and Molecular Morphology. Natick, MA: Eaton; 2000:255-272.
87. Taylor CR, Shi SR, Barr NJ, et al. Techniques of immunohistochemistry: principles, pitfalls, and standardization. In: Dabbs DJ, ed. Diagnostic Immunohistochemistry. 4th ed. New York, NY: Churchill Livingstone Elsevier; 2014:1-38.
88. Prichard J. Quality management and regulation. In: Lin F, Prichard JW, Liu H, Wilkerson M, Schuerch C, eds. Handbook of Practical Immunohistochemistry-Frequently Asked Questions. New York, NY: Springer; 2011:1-15.
89. Elias JM. Immunohistochemical methods. In: Immunohistopathology: A Practical Approach to Diagnosis. 2nd ed. Chicago, IL: ASCP Press; 2003:1-110.
90. Fitzgibbons PL, Bradley LA, Fatheree LA, et al. Principles of analytic validation of immunohistochemical assays. [published online ahead of print March 19, 2014]. Arch Pathol Lab Med. doi:10.5858/arpa.2013-0610-CP.
91. Wolff AC, Hammond ME, Hicks DG, et al; American Society of Clinical Oncology; College of American Pathologists. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. Arch Pathol Lab Med. 2014;138(2):241-256.
92. Wolff AC, Hammond ME, Hicks DG, et al; American Society of Clinical Oncology; College of American Pathologists. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31(31):3997-4013.
93. Hammond ME. ASCO-CAP guidelines for breast predictive factor testing: an update. Appl Immunohistochem Mol Morphol. 2011;19(6):499-500.
94. Hammond ME, Hayes DF, Dowsett M, et al; American Society of Clinical Oncology; College of American Pathologists. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med. 2010;134(7):e48-e72.
95. Bussolati G, Leonardo E. Technical pitfalls potentially affecting diagnoses in immunohistochemistry. J Clin Pathol. 2008;61(11):1184-1192.
96. Du J, Liu JY, Su J. Comparison of two different tissue decalcification methods for immunohistochemistry [in Chinese]. Beijing Da Xue Xue Bao. 2011;43(2):290-294.
97. CAP checklists 2013 for anatomic pathology. http://www.cap.org. Accessed November 30, 2013.
98. Geisinger IHCWeb site. http://www.ihcfaq.com. Accessed November 30, 2013.
99. Lin F, Shi J. Technique and troubleshooting of antibody testing. In: Lin F, Prichard JW, Liu H, Wilkerson M, Schuerch C, eds. Handbook of Practical Immunohistochemistry-Frequently Asked Questions. New York, NY: Springer; 2011:17-21.
100. Ordóñez NG, Napsin A expression in lung and kidney neoplasia: a review and update. Adv Anat Pathol. 2012;19(1):66-73.
101. Klipp J. Medicare claims trends. In: Klipp J, ed. The US Anatomic Pathology Market: Forecast & Trends 2012. Poughkeepsie, NY: Laboratory Economics LLC; 2012:13.
102. Kakar S, Gown AM, Goodman ZD, Ferrell LD. Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms. Arch Pathol Lab Med. 2007;131(11):1648-1654.
103. Paner GP, Luthringer DJ, Amin MB. Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies. Arch Pathol Lab Med. 2008;132(9):1388-1396.
104. Turner MS, Goldsmith JD. Best practices in diagnostic immunohistochemistry: spindle cell neoplasms of the gastrointestinal tract. Arch Pathol Lab Med. 2009;133(9):1370-1374.
105. Zhao L, Yang X, Khan A, Kandil D. Diagnostic role of immunohistochemistry in the evaluation of breast pathology specimens. Arch Pathol Lab Med. 2014;138(1):16-24.
106. Dunphy CH. Applications of flow cytometry and immunohistochemistry to diagnostic hematopathology. Arch Pathol Lab Med. 2004;128(9):1004-1022.
107. Yoshida A, Sekine S, Tsuta K, Fukayama M, Furuta K, Tsuda H. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Am J Surg Pathol. 2012;36(7):993-999.